Drug Markets/Trandolapril and Verapamil Hydrochloride

Trandolapril and Verapamil Hydrochloride

1 NDC across 1 manufacturer|1 Generic,0 Brand

▸ More about this market

Trandolapril and Verapamil Hydrochloride is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $3.64 to $3.64 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1G / 0B

Manufacturers

competing in market

Price Spread

$3.64 – $3.64

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE

Glenmark Pharmaceuticals Inc., USA

1 NDC

$3.6356

avg/unit

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET	68462032901	Glenmark Pharmaceuticals Inc., USA	$3.6356 per EA	—	Generic	—	Angiotensin Converting Enzyme Inhibitor, Calcium Channel Blocker

Frequently Asked Questions

How many Trandolapril and Verapamil Hydrochloride products are on the market?

The Trandolapril and Verapamil Hydrochloride drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.

What is the price range for Trandolapril and Verapamil Hydrochloride?

NADAC reference prices for Trandolapril and Verapamil Hydrochloride range from $3.6356 to $3.6356 per EA.

Which manufacturers make Trandolapril and Verapamil Hydrochloride?

1 manufacturer lists Trandolapril and Verapamil Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Glenmark Pharmaceuticals Inc., USA (1).